OLIGONUKLEOTIDE ZUR MODULATION DER RTEL1-EXPRESSION
European patent · EP3821013 · In force
Register entry
- Publication number
- EP3821013
- Application number
- EP19739971
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 11, 2019
- Published
- May 19, 2021
- Granted
- Nov 27, 2024
- Protection ends at the latest
- Jul 10, 2039
- Next annual fee due
- Jul 31, 2027
- IPC classes
- C12N 15/113 (2010.01)A61K 31/712 (2006.01)A61K 31/7125 (2006.01)
- Priority
- EP 18183477 13.07.2018
- PCT application
- PCT/EP2019/068639 11.07.2019
- PCT publication
- WO2020/011902 16.01.2020
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.07.2026 → 31.07.2027
Published in Swissreg on 01.08.2026
- Oct 8, 2025
Change
Published in Swissreg on 08.10.2025
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.07.2025 → 31.07.2026
Published in Swissreg on 01.08.2025
- Nov 27, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 27.11.2024
Parties
Inventor
BERRERA, Marco
4070 Basel
FELBER, Josephine
4070 Basel
HOFLACK, Jean-Christophe
4070 Basel
KAMMLER, Susanne
2970 Hørsholm, DK
KAM-THONG, Tony
4070 Basel
LEONARD, Brian
4070 Basel
PEDERSEN, Lykke
2970 Horsholm, DK
TROPBERGER, Philipp
4070 Basel
TRIYATNI, Miriam
4070 Basel
TURLEY, Daniel Jeremy
4070 Basel
WALLIER, Angelina
4070 Basel
ZHANG, Jitao David
4070 Basel
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.